0.015069
0.008700
0.000000
0.000000
0.017401
0.000000
0.000000
0.000000
0.012480
0.00000
0.00000
0.00000
Mace, J.E.
Agard, D.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
6
90.00
90.00
120.00
66.360
66.360
80.130
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C2 H8 B N O2
88.901
n
ALANINE BORONIC ACID
peptide-like
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H8 O4
132.115
SUCCINIC ACID MONOMETHYL ESTER
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
O4 S -2
96.063
SULFATE ION
non-polymer
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
254
720
736
10.1006/jmbi.1995.0650
7500345
Kinetic and structural characterization of mutations of glycine 216 in alpha-lytic protease: a new target for engineering substrate specificity.
1995
US
Biochemistry
BICHAW
0033
0006-2960
30
10388
Structural Basis for Broad Specificity in Alpha-Lytic Protease
1991
UK
Nature
NATUAS
0006
0028-0836
339
191
Structural Plasticity Broadens the Specificity of an Engineered Protease
1989
US
Biochemistry
BICHAW
0033
0006-2960
28
7600
Structural Analysis of Specificity: Alpha-Lytic Protease Complexes with Analogues of Reaction Intermediates
1989
US
Biochemistry
BICHAW
0033
0006-2960
27
7609
Serine Protease Mechanism: Structure of an Inhibitory Complex of Alpha-Lytic Protease and a Tightly Bound Peptide Boronic Acid
1987
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
184
479
Refined Structure of Alpha-Lytic Protease at 1.7 Angstroms Resolution. Analysis of Hydrogen Bonding and Solvent Structure
1985
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
131
743
Molecular Structure of the Alpha-Lytic Protease from Myxobacter 495 at 2.8 Angstroms Resolution
1979
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
DIFFRACTOMETER
1991-08-05
RIGAKU AFC-6R
M
x-ray
1
1.5418
1.0
1.5418
19815.014
ALPHA-LYTIC PROTEASE
3.4.21.12
M190A
1
man
polymer
442.271
METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID INHIBITOR
1
syn
polymer
96.063
SULFATE ION
2
syn
non-polymer
18.015
water
139
nat
water
no
no
ANIVGGIEYSINNASLCSVGFSVTRGATKGFVTAGHCGTVNATARIGGAVVGTFAARVFPGNDRAWVSLTSAQTLLPRVA
NGSSFVTVRGSTEAAVGAAVCRSGRTTGYQCGTITAKNVTANYAEGAVRGLTQGNACAGRGDSGGSWITSAGQAQGVMSG
GNVQSNGNNCGIPASQRSSLFERLQPILSQYGLSLVTG
ANIVGGIEYSINNASLCSVGFSVTRGATKGFVTAGHCGTVNATARIGGAVVGTFAARVFPGNDRAWVSLTSAQTLLPRVA
NGSSFVTVRGSTEAAVGAAVCRSGRTTGYQCGTITAKNVTANYAEGAVRGLTQGNACAGRGDSGGSWITSAGQAQGVMSG
GNVQSNGNNCGIPASQRSSLFERLQPILSQYGLSLVTG
A
polypeptide(L)
no
yes
(MSU)AAP(B2A)
XAAPA
P
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lysobacter
495
Escherichia
sample
29487
ALPHA-LYTIC PROTEASE PREPROENZ
69
Lysobacter enzymogenes
ALPHA-LYTIC PROTEASE PREPROENZYME
562
Escherichia coli
PALP12 (PBR322-DERIVATIVE)
2.51
51.07
repository
Initial release
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Version format compliance
Other
1
0
1996-01-29
1
1
2008-03-24
1
2
2011-07-13
1
3
2012-12-12
1996-01-29
SPRSDE
Y
1995-09-06
REL
REL
SO4
SULFATE ION
HOH
water
INHIBITORY PEPTIDE BORONIC ACIDS ARE PEPTIDE ANALOGS IN WHICH THE C-TERMINAL CARBOXYL GROUP HAS BEEN REPLACED WITH THE BORONIC ACID GROUP (B(OH)2).
CHAIN A RESIDUE NUMBERING IS DONE BY HOMOLOGY WITH CHYMOTRYPSIN FOR RESIDUES 15A - 245. CHAIN P INHIBITOR NUMBERING IS DONE BY ANALOGY TO PROTEASE SUBSTRATE NOMENCLATURE IN WHICH THE RESIDUE PRIOR TO THE SCISSILE BOND IS THE P1 RESIDUE, THE NEXT TOWARD THE N-TERMINUS IS THE P2 RESIDUE, ETC.
Inhibitor
METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID
Peptide-like
SO4
1
3
SO4
SO4
1
A
SO4
2
3
SO4
SO4
2
A
HOH
3
4
HOH
HOH
246
A
HOH
4
4
HOH
HOH
247
A
HOH
5
4
HOH
HOH
248
A
HOH
6
4
HOH
HOH
249
A
HOH
7
4
HOH
HOH
250
A
HOH
8
4
HOH
HOH
251
A
HOH
9
4
HOH
HOH
252
A
HOH
10
4
HOH
HOH
253
A
HOH
11
4
HOH
HOH
254
A
HOH
12
4
HOH
HOH
255
A
HOH
13
4
HOH
HOH
256
A
HOH
14
4
HOH
HOH
257
A
HOH
15
4
HOH
HOH
258
A
HOH
16
4
HOH
HOH
259
A
HOH
17
4
HOH
HOH
260
A
HOH
18
4
HOH
HOH
261
A
HOH
19
4
HOH
HOH
262
A
HOH
20
4
HOH
HOH
263
A
HOH
21
4
HOH
HOH
264
A
HOH
22
4
HOH
HOH
265
A
HOH
23
4
HOH
HOH
266
A
HOH
24
4
HOH
HOH
267
A
HOH
25
4
HOH
HOH
268
A
HOH
26
4
HOH
HOH
269
A
HOH
27
4
HOH
HOH
270
A
HOH
28
4
HOH
HOH
271
A
HOH
29
4
HOH
HOH
272
A
HOH
30
4
HOH
HOH
273
A
HOH
31
4
HOH
HOH
274
A
HOH
32
4
HOH
HOH
275
A
HOH
33
4
HOH
HOH
276
A
HOH
34
4
HOH
HOH
277
A
HOH
35
4
HOH
HOH
278
A
HOH
36
4
HOH
HOH
279
A
HOH
37
4
HOH
HOH
280
A
HOH
38
4
HOH
HOH
281
A
HOH
39
4
HOH
HOH
282
A
HOH
40
4
HOH
HOH
283
A
HOH
41
4
HOH
HOH
284
A
HOH
42
4
HOH
HOH
285
A
HOH
43
4
HOH
HOH
286
A
HOH
44
4
HOH
HOH
287
A
HOH
45
4
HOH
HOH
288
A
HOH
46
4
HOH
HOH
289
A
HOH
47
4
HOH
HOH
290
A
HOH
48
4
HOH
HOH
291
A
HOH
49
4
HOH
HOH
292
A
HOH
50
4
HOH
HOH
293
A
HOH
51
4
HOH
HOH
294
A
HOH
52
4
HOH
HOH
295
A
HOH
53
4
HOH
HOH
296
A
HOH
54
4
HOH
HOH
297
A
HOH
55
4
HOH
HOH
298
A
HOH
56
4
HOH
HOH
299
A
HOH
57
4
HOH
HOH
300
A
HOH
58
4
HOH
HOH
301
A
HOH
59
4
HOH
HOH
302
A
HOH
60
4
HOH
HOH
303
A
HOH
61
4
HOH
HOH
304
A
HOH
62
4
HOH
HOH
305
A
HOH
63
4
HOH
HOH
306
A
HOH
64
4
HOH
HOH
307
A
HOH
65
4
HOH
HOH
308
A
HOH
66
4
HOH
HOH
309
A
HOH
67
4
HOH
HOH
310
A
HOH
68
4
HOH
HOH
311
A
HOH
69
4
HOH
HOH
312
A
HOH
70
4
HOH
HOH
313
A
HOH
71
4
HOH
HOH
314
A
HOH
72
4
HOH
HOH
315
A
HOH
73
4
HOH
HOH
316
A
HOH
74
4
HOH
HOH
317
A
HOH
75
4
HOH
HOH
318
A
HOH
76
4
HOH
HOH
319
A
HOH
77
4
HOH
HOH
320
A
HOH
78
4
HOH
HOH
321
A
HOH
79
4
HOH
HOH
322
A
HOH
80
4
HOH
HOH
323
A
HOH
81
4
HOH
HOH
324
A
HOH
82
4
HOH
HOH
325
A
HOH
83
4
HOH
HOH
326
A
HOH
84
4
HOH
HOH
327
A
HOH
85
4
HOH
HOH
328
A
HOH
86
4
HOH
HOH
329
A
HOH
87
4
HOH
HOH
330
A
HOH
88
4
HOH
HOH
331
A
HOH
89
4
HOH
HOH
332
A
HOH
90
4
HOH
HOH
333
A
HOH
91
4
HOH
HOH
334
A
HOH
92
4
HOH
HOH
335
A
HOH
93
4
HOH
HOH
336
A
HOH
94
4
HOH
HOH
337
A
HOH
95
4
HOH
HOH
338
A
HOH
96
4
HOH
HOH
339
A
HOH
97
4
HOH
HOH
340
A
HOH
98
4
HOH
HOH
341
A
HOH
99
4
HOH
HOH
342
A
HOH
100
4
HOH
HOH
343
A
HOH
101
4
HOH
HOH
344
A
HOH
102
4
HOH
HOH
345
A
HOH
103
4
HOH
HOH
346
A
HOH
104
4
HOH
HOH
347
A
HOH
105
4
HOH
HOH
348
A
HOH
106
4
HOH
HOH
349
A
HOH
107
4
HOH
HOH
350
A
HOH
108
4
HOH
HOH
351
A
HOH
109
4
HOH
HOH
352
A
HOH
110
4
HOH
HOH
353
A
HOH
111
4
HOH
HOH
354
A
HOH
112
4
HOH
HOH
355
A
HOH
113
4
HOH
HOH
356
A
HOH
114
4
HOH
HOH
357
A
HOH
115
4
HOH
HOH
358
A
HOH
116
4
HOH
HOH
359
A
HOH
117
4
HOH
HOH
360
A
HOH
118
4
HOH
HOH
361
A
HOH
119
4
HOH
HOH
362
A
HOH
120
4
HOH
HOH
363
A
HOH
121
4
HOH
HOH
364
A
HOH
122
4
HOH
HOH
365
A
HOH
123
4
HOH
HOH
366
A
HOH
124
4
HOH
HOH
367
A
HOH
125
4
HOH
HOH
368
A
HOH
126
4
HOH
HOH
369
A
HOH
127
4
HOH
HOH
370
A
HOH
128
4
HOH
HOH
371
A
HOH
129
4
HOH
HOH
372
A
HOH
130
4
HOH
HOH
373
A
HOH
131
4
HOH
HOH
374
A
HOH
132
4
HOH
HOH
375
A
HOH
133
4
HOH
HOH
376
A
HOH
134
4
HOH
HOH
377
A
HOH
135
4
HOH
HOH
378
A
HOH
136
4
HOH
HOH
379
A
HOH
137
4
HOH
HOH
380
A
HOH
138
4
HOH
HOH
381
A
HOH
139
4
HOH
HOH
382
A
HOH
140
4
HOH
HOH
383
A
HOH
141
4
HOH
HOH
384
A
ALA
15
n
1
A
ALA
15
A
ASN
15
n
2
B
ASN
15
A
ILE
16
n
3
ILE
16
A
VAL
17
n
4
VAL
17
A
GLY
18
n
5
GLY
18
A
GLY
19
n
6
GLY
19
A
ILE
31
n
7
ILE
31
A
GLU
32
n
8
GLU
32
A
TYR
33
n
9
TYR
33
A
SER
34
n
10
SER
34
A
ILE
35
n
11
ILE
35
A
ASN
36
n
12
ASN
36
A
ASN
38
n
13
ASN
38
A
ALA
39
n
14
ALA
39
A
SER
40
n
15
SER
40
A
LEU
41
n
16
LEU
41
A
CYS
42
n
17
CYS
42
A
SER
43
n
18
SER
43
A
VAL
44
n
19
VAL
44
A
GLY
44
n
20
A
GLY
44
A
PHE
45
n
21
PHE
45
A
SER
46
n
22
SER
46
A
VAL
47
n
23
VAL
47
A
THR
48
n
24
THR
48
A
ARG
48
n
25
A
ARG
48
A
GLY
48
n
26
B
GLY
48
A
ALA
48
n
27
C
ALA
48
A
THR
49
n
28
THR
49
A
LYS
50
n
29
LYS
50
A
GLY
51
n
30
GLY
51
A
PHE
52
n
31
PHE
52
A
VAL
53
n
32
VAL
53
A
THR
54
n
33
THR
54
A
ALA
55
n
34
ALA
55
A
GLY
56
n
35
GLY
56
A
HIS
57
n
36
HIS
57
A
CYS
58
n
37
CYS
58
A
GLY
59
n
38
GLY
59
A
THR
59
n
39
A
THR
59
A
VAL
59
n
40
B
VAL
59
A
ASN
60
n
41
ASN
60
A
ALA
61
n
42
ALA
61
A
THR
62
n
43
THR
62
A
ALA
64
n
44
ALA
64
A
ARG
65
n
45
ARG
65
A
ILE
66
n
46
ILE
66
A
GLY
67
n
47
GLY
67
A
GLY
81
n
48
GLY
81
A
ALA
82
n
49
ALA
82
A
VAL
83
n
50
VAL
83
A
VAL
84
n
51
VAL
84
A
GLY
85
n
52
GLY
85
A
THR
87
n
53
THR
87
A
PHE
88
n
54
PHE
88
A
ALA
88
n
55
A
ALA
88
A
ALA
89
n
56
ALA
89
A
ARG
90
n
57
ARG
90
A
VAL
91
n
58
VAL
91
A
PHE
94
n
59
PHE
94
A
PRO
95
n
60
PRO
95
A
GLY
100
n
61
GLY
100
A
ASN
101
n
62
ASN
101
A
ASP
102
n
63
ASP
102
A
ARG
103
n
64
ARG
103
A
ALA
104
n
65
ALA
104
A
TRP
105
n
66
TRP
105
A
VAL
106
n
67
VAL
106
A
SER
107
n
68
SER
107
A
LEU
108
n
69
LEU
108
A
THR
109
n
70
THR
109
A
SER
110
n
71
SER
110
A
ALA
111
n
72
ALA
111
A
GLN
112
n
73
GLN
112
A
THR
113
n
74
THR
113
A
LEU
114
n
75
LEU
114
A
LEU
119
n
76
LEU
119
A
PRO
120
n
77
PRO
120
A
ARG
120
n
78
A
ARG
120
A
VAL
120
n
79
B
VAL
120
A
ALA
120
n
80
C
ALA
120
A
ASN
120
n
81
D
ASN
120
A
GLY
120
n
82
E
GLY
120
A
SER
120
n
83
G
SER
120
A
SER
120
n
84
H
SER
120
A
PHE
120
n
85
I
PHE
120
A
VAL
120
n
86
J
VAL
120
A
THR
120
n
87
K
THR
120
A
VAL
121
n
88
VAL
121
A
ARG
122
n
89
ARG
122
A
GLY
123
n
90
GLY
123
A
SER
124
n
91
SER
124
A
THR
125
n
92
THR
125
A
GLU
129
n
93
GLU
129
A
ALA
130
n
94
ALA
130
A
ALA
131
n
95
ALA
131
A
VAL
132
n
96
VAL
132
A
GLY
133
n
97
GLY
133
A
ALA
134
n
98
ALA
134
A
ALA
135
n
99
ALA
135
A
VAL
136
n
100
VAL
136
A
CYS
137
n
101
CYS
137
A
ARG
138
n
102
ARG
138
A
SER
139
n
103
SER
139
A
GLY
140
n
104
GLY
140
A
ARG
141
n
105
ARG
141
A
THR
142
n
106
THR
142
A
THR
143
n
107
THR
143
A
GLY
156
n
108
GLY
156
A
TYR
157
n
109
TYR
157
A
GLN
158
n
110
GLN
158
A
CYS
159
n
111
CYS
159
A
GLY
160
n
112
GLY
160
A
THR
161
n
113
THR
161
A
ILE
162
n
114
ILE
162
A
THR
163
n
115
THR
163
A
ALA
164
n
116
ALA
164
A
LYS
165
n
117
LYS
165
A
ASN
166
n
118
ASN
166
A
VAL
167
n
119
VAL
167
A
THR
168
n
120
THR
168
A
ALA
169
n
121
ALA
169
A
ASN
170
n
122
ASN
170
A
TYR
171
n
123
TYR
171
A
ALA
173
n
124
ALA
173
A
GLU
174
n
125
GLU
174
A
GLY
175
n
126
GLY
175
A
ALA
176
n
127
ALA
176
A
VAL
177
n
128
VAL
177
A
ARG
178
n
129
ARG
178
A
GLY
179
n
130
GLY
179
A
LEU
180
n
131
LEU
180
A
THR
181
n
132
THR
181
A
GLN
182
n
133
GLN
182
A
GLY
183
n
134
GLY
183
A
ASN
184
n
135
ASN
184
A
ALA
185
n
136
ALA
185
A
CYS
189
n
137
CYS
189
A
ALA
190
n
138
ALA
190
A
GLY
191
n
139
GLY
191
A
ARG
192
n
140
ARG
192
A
GLY
193
n
141
GLY
193
A
ASP
194
n
142
ASP
194
A
SER
195
n
143
SER
195
A
GLY
196
n
144
GLY
196
A
GLY
197
n
145
GLY
197
A
SER
198
n
146
SER
198
A
TRP
199
n
147
TRP
199
A
ILE
200
n
148
ILE
200
A
THR
201
n
149
THR
201
A
SER
201
n
150
A
SER
201
A
ALA
202
n
151
ALA
202
A
GLY
207
n
152
GLY
207
A
GLN
208
n
153
GLN
208
A
ALA
209
n
154
ALA
209
A
GLN
210
n
155
GLN
210
A
GLY
211
n
156
GLY
211
A
VAL
212
n
157
VAL
212
A
MET
213
n
158
MET
213
A
SER
214
n
159
SER
214
A
GLY
215
n
160
GLY
215
A
GLY
216
n
161
GLY
216
A
ASN
217
n
162
ASN
217
A
VAL
218
n
163
VAL
218
A
GLN
219
n
164
GLN
219
A
SER
219
n
165
A
SER
219
A
ASN
219
n
166
B
ASN
219
A
GLY
219
n
167
C
GLY
219
A
ASN
219
n
168
D
ASN
219
A
ASN
220
n
169
ASN
220
A
CYS
220
n
170
A
CYS
220
A
GLY
221
n
171
GLY
221
A
ILE
222
n
172
ILE
222
A
PRO
222
n
173
A
PRO
222
A
ALA
222
n
174
B
ALA
222
A
SER
222
n
175
C
SER
222
A
GLN
223
n
176
GLN
223
A
ARG
224
n
177
ARG
224
A
SER
225
n
178
SER
225
A
SER
226
n
179
SER
226
A
LEU
227
n
180
LEU
227
A
PHE
228
n
181
PHE
228
A
GLU
229
n
182
GLU
229
A
ARG
230
n
183
ARG
230
A
LEU
231
n
184
LEU
231
A
GLN
232
n
185
GLN
232
A
PRO
233
n
186
PRO
233
A
ILE
234
n
187
ILE
234
A
LEU
235
n
188
LEU
235
A
SER
236
n
189
SER
236
A
GLN
237
n
190
GLN
237
A
TYR
238
n
191
TYR
238
A
GLY
239
n
192
GLY
239
A
LEU
240
n
193
LEU
240
A
SER
241
n
194
SER
241
A
LEU
242
n
195
LEU
242
A
VAL
243
n
196
VAL
243
A
THR
244
n
197
THR
244
A
GLY
245
n
198
GLY
245
A
n
1
5
P
ALA
4
n
2
ALA
4
P
ALA
3
n
3
ALA
3
P
PRO
2
n
4
PRO
2
P
B2A
1
n
5
B2A
1
P
author_and_software_defined_assembly
PISA
2
dimeric
1060
-21
7860
P
B2A
1
ALANINE BORONIC ACID
B
B2A
5
ALA
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
TYR
33
A
O
TYR
9
A
N
CYS
42
A
N
CYS
17
A
O
PHE
45
A
O
PHE
21
A
N
VAL
53
A
N
VAL
32
A
O
PHE
52
A
O
PHE
31
A
N
VAL
106
A
N
VAL
67
A
O
ARG
103
A
O
ARG
64
A
N
VAL
91
A
N
VAL
58
A
O
ALA
82
A
O
ALA
49
A
N
ILE
66
A
N
ILE
46
B
A
O
VAL
120
A
O
VAL
79
J
A
N
VAL
120
A
N
VAL
86
A
O
VAL
136
A
O
VAL
100
A
N
GLY
160
A
N
GLY
112
A
O
ALA
169
A
O
ALA
121
A
N
VAL
177
A
N
VAL
128
A
O
THR
181
A
O
THR
132
A
N
PHE
228
A
N
PHE
181
A
O
LEU
227
A
O
LEU
180
A
N
GLY
215
A
N
GLY
160
A
O
GLN
210
A
O
GLN
155
A
N
TRP
199
A
N
TRP
147
1
P
MSU
5
B
MSU
1
1
Y
A
A
A
1
-5.26
0.50
120.30
115.04
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
48
48
48
N
1
3.97
0.50
120.30
124.27
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
65
65
65
N
1
4.44
0.50
120.30
124.74
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
90
90
90
N
1
6.66
0.80
106.30
112.96
A
A
A
CD1
CG
CD2
TRP
TRP
TRP
105
105
105
N
1
-5.89
0.80
107.30
101.41
A
A
A
CE2
CD2
CG
TRP
TRP
TRP
105
105
105
N
A
A
A
1
3.06
0.50
120.30
123.36
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
120
120
120
N
1
-13.04
2.10
111.80
98.76
A
A
A
CG
CD
NE
ARG
ARG
ARG
122
122
122
N
1
7.21
0.50
120.30
127.51
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
122
122
122
N
1
-7.61
0.50
120.30
112.69
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
122
122
122
N
1
-3.14
0.50
120.30
117.16
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
178
178
178
N
1
6.29
0.80
106.30
112.59
A
A
A
CD1
CG
CD2
TRP
TRP
TRP
199
199
199
N
1
-5.56
0.80
107.30
101.74
A
A
A
CE2
CD2
CG
TRP
TRP
TRP
199
199
199
N
1
A
A
NE2
CD2
HIS
HIS
57
57
-0.067
0.011
1.373
1.306
N
1
A
ALA
39
-138.85
-80.19
1
A
PRO
95
-76.14
-159.54
1
A
PRO
120
-82.54
49.32
1
A
SER
214
-103.79
-62.32
THE METHOXYSUCCINYL PORTION OF THE INHIBITOR WAS DISORDERED AND NO COORDINATES ARE INCLUDED FOR IT IN THIS ENTRY
0.134
0.134
2.13
17.5
11560
1
2.0
2.13
17.5
139
1560
10
0
1411
0.014
2.6
25.9
1.26
2.13
17.5
1GBK
11778
1
82.0
data collection
RIGAKU
AFC5 CONTROL SOFTWARE
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
data reduction
RIGAKU
AFC5 CONTROL SOFTWARE
phasing
X-PLOR
3.1
ALPHA-LYTIC PROTEASE, METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID
ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID
1
N
N
2
N
N
3
N
N
3
N
N
4
N
N
A
GLY
56
A
GLY
35
HELX_P
A
CYS
58
A
CYS
37
5
1
3
A
ALA
222
A
ALA
174
HELX_P
A
GLN
223
A
GLN
176
5
2
3
B
A
LEU
231
A
LEU
184
HELX_P
A
TYR
238
A
TYR
191
1
3
8
disulf
2.036
A
CYS
42
A
SG
CYS
17
1_555
A
CYS
58
A
SG
CYS
37
1_555
disulf
2.014
A
CYS
137
A
SG
CYS
101
1_555
A
CYS
159
A
SG
CYS
111
1_555
disulf
2.007
A
A
CYS
189
A
SG
CYS
137
1_555
A
CYS
220
A
SG
CYS
170
1_555
covale
1.333
P
B2A
1
B
N
B2A
5
1_555
P
PRO
2
B
C
PRO
4
1_555
covale
1.381
P
B2A
1
B
B
B2A
5
1_555
A
SER
195
A
OG
SER
143
1_555
HYDROLASE/HYDROLASE INHIBITOR
ACTIVE-SITE MUTATION, SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
A
PHE
94
A
PHE
59
1
A
PRO
95
A
PRO
60
-11.18
PRLA_LYSEN
UNP
1
1
P00778
MYVSNHRSRRVARVSVSCLVAALAAMSCGAALAADQVDPQLKFAMQRDLGIFPTQLPQYLQTEKLARTQAAAIEREFGAQ
FAGSWIERNEDGSFKLVAATSGARKSSTLGGVEVRNVRYSLKQLQSAMEQLDAGANARVKGVSKPLDGVQSWYVDPRSNA
VVVKVDDGATEAGVDFVALSGADSAQVRIESSPGKLQTTANIVGGIEYSINNASLCSVGFSVTRGATKGFVTAGHCGTVN
ATARIGGAVVGTFAARVFPGNDRAWVSLTSAQTLLPRVANGSSFVTVRGSTEAAVGAAVCRSGRTTGYQCGTITAKNVTA
NYAEGAVRGLTQGNACMGRGDSGGSWITSAGQAQGVMSGGNVQSNGNNCGIPASQRSSLFERLQPILSQYGLSLVTG
1GBK
PDB
2
1
1GBK
(MSU)AAP(B2A)
200
397
1GBK
15
245
P00778
A
A
1
1
198
5
1
1GBK
1
5
1GBK
P
2
5
1
1
MET
ENGINEERED MUTATION
ALA
190
1GBK
A
P00778
UNP
337
138
2
5
2
2
2
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
32
A
GLU
8
A
ILE
35
A
ILE
11
A
SER
40
A
SER
15
A
SER
43
A
SER
18
A
PHE
45
A
PHE
21
A
ARG
48
A
ARG
25
A
A
THR
49
A
THR
28
A
THR
54
A
THR
33
A
ARG
103
A
ARG
64
A
LEU
108
A
LEU
69
A
ALA
82
A
ALA
49
A
VAL
91
A
VAL
58
A
THR
62
A
THR
43
A
ILE
66
A
ILE
46
A
ARG
120
A
ARG
78
A
ASN
120
A
ASN
81
A
D
A
SER
120
A
SER
84
A
THR
120
A
THR
87
H
K
A
ALA
135
A
ALA
99
A
GLY
140
A
GLY
104
A
GLY
156
A
GLY
108
A
THR
161
A
THR
113
A
ALA
169
A
ALA
121
A
TYR
171
A
TYR
123
A
GLY
175
A
GLY
126
A
VAL
177
A
VAL
128
A
THR
181
A
THR
132
A
GLY
183
A
GLY
134
A
SER
226
A
SER
179
A
ARG
230
A
ARG
183
A
ALA
209
A
ALA
154
A
GLY
216
A
GLY
161
A
SER
198
A
SER
146
A
ILE
200
A
ILE
148
BINDING SITE FOR RESIDUE SO4 A 1
Software
7
BINDING SITE FOR RESIDUE SO4 A 2
Software
6
BINDING SITE FOR CHAIN P OF METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID INHIBITOR
Software
10
A
SER
120
A
SER
83
G
7
4_555
A
GLY
123
A
GLY
90
7
5_565
A
SER
124
A
SER
91
7
5_565
A
THR
125
A
THR
92
7
5_565
A
ARG
192
A
ARG
140
7
1_555
A
HOH
254
E
HOH
7
5_565
A
HOH
294
E
HOH
7
5_565
A
ALA
15
A
ALA
1
A
6
3_665
A
ASN
15
A
ASN
2
B
6
3_665
A
ARG
230
A
ARG
183
6
1_555
A
PRO
233
A
PRO
186
6
1_555
A
HOH
270
E
HOH
6
3_665
A
HOH
366
E
HOH
6
3_665
A
HIS
57
A
HIS
36
10
1_555
A
ARG
122
A
ARG
89
10
5_565
A
TYR
171
A
TYR
123
10
1_555
A
GLY
193
A
GLY
141
10
1_555
A
ASP
194
A
ASP
142
10
1_555
A
SER
195
A
SER
143
10
1_555
A
SER
214
A
SER
159
10
1_555
A
GLY
215
A
GLY
160
10
1_555
A
GLY
216
A
GLY
161
10
1_555
A
HOH
355
E
HOH
10
5_565
154
P 32 2 1